[White Paper] Meeting the challenge of synthesizing complex therapeutic peptides

While many therapeutic peptides are variants of natural peptides, advances in Solid Phase Peptide Synthesis has enabled the design of more refined molecules that are more readily able to penetrate the cell membrane, more stable, and resistant to degradation. The demand for increasingly complex therapeutic peptides has resulted in the development of robust, efficient, and rapid synthesis protocols and instrumentation that can meet the demands of GxP and regulatory authorities. Download the white paper to read more about synthesizing complex therapeutic peptides.

Download White Paper